Abstract: The present invention relates to a composition comprising ?-lipoic acid, Salvia miltiorrhiza extract and Curcumin, optionally further comprising ?-linolenic acid or borage oil. Furthermore, the present invention relates to the use of such composition for treating neuropathies.

Abstract: A composition containing a synergistic association of lactitol, lactulose and Rhamnus frangula extract for the treatment of constipation is described.

Abstract: The present invention relates to a composition for oral use comprising an extract of Tamarindus indica, hyaluronic acid and/or its salts and at least one block copolymer of ethylene oxide and propylene oxide for the treatment of gastric and oesophageal diseases, in particular gastroesophageal reflux.

Abstract: The present invention relates to a composition comprising as active ingredients an extract of Cetraria islandica, silver and/or a salt thereof and hyaluronic acid and/or a salt thereof. The present invention further relates to the use of such composition for the treatment of skin and/or mucous membrane diseases.

Abstract: The present invention relates to a pharmaceutical composition which contains activated charcoal, Carum carvi extract, papain and, optionally, ?-galactosidase and ?-galactosidase for the treatment of gastrointestinal disorders.

Abstract: A synergistic composition of naturally occurring active ingredients is described, which has proved particularly effective in the treatment and/or prevention of epistaxis, particularly in acute or chronic episodes of infectious and inflammatory epistaxis. The composition includes the synergistic combination of hyaluronic acid or a salt thereof, silver, vitamin B5 or pro-vitamin B5, and optionally vitamin E or an ester thereof.

Abstract: Provided herein is a composition of substances preferably obtained from natural sources, which is effective in preventing and/or treating iron deficiency conditions or diseases. The composition includes iron pyrophosphate, phosphatidylserine, phosphatidylcholine and starch, preferably acetylated pregelatinised starch. The formulation gives the composition gastro-resistance properties and high bioavailability of the active ingredient iron pyrophosphate. The composition is prepared in the form of a solid, semi-solid or liquid pharmaceutical dosage, preferably for oral administration.

Abstract: The present invention relates to a composition comprising an extract of a plant belonging to the genus Malus, an extract of Olea europaea and policosanols and to the use thereof in reducing plasma cholesterol levels and cardiovascular risk.

Abstract: The present invention relates to a composition for oral use comprising at least an extract of red yeast rice, at least an extract of a plant belonging to the genus Allium and at least an extract of a plant belonging to the genus Malus and to the use thereof for the prevention and/or treatment of hypercholesterolemia, the main cardiovascular risk factor.

Abstract: The present invention relates to a pharmaceutical composition for use in the treatment of prostate pathologies. The present invention further relates to a composition comprising a mixture which comprises or, alternatively, consists of an effective amount of Serenoa repens, Bromelain, Curcumin, Zinc, Lycopene and Selenium, and pharmaceutically acceptable or food grade technological excipients and/or additives. The present invention further relates to a pharmaceutical composition, preferably in the form of softgel capsules, for use in the treatment of disorders or diseases or pathologies connected to and/or deriving from prostatitis and/or benign prostatic hyperplasia.

Abstract: The present invention relates to a composition comprising or, alternatively, consisting of an effective amount of a mixture which comprises at least, or consists of: a) an extract of Pelargonium sidoides; b) an extract of Adhatoda vasica; and c) N-acetyl cysteine for use in a method for the preventive or therapeutic treatment of at least one respiratory tract disorder in a subject, wherein said treatment method comprises the administration of said composition to the subject.

Abstract: A synergistic composition of naturally occurring active ingredients is described, which has proved particularly effective in the treatment and/or prevention of epistaxis, particularly in acute or chronic episodes of infectious and inflammatory epistaxis. The composition includes the synergistic combination of hyaluronic acid or a salt thereof, silver, vitamin B5 or pro-vitamin B5, and optionally vitamin E or an ester thereof.

Abstract: A synergistic composition of active ingredients which is particularly effective in the treatment and/or prevention of irritable bowel syndrome is provided. The composition includes the synergistic combination of butyric acid or a salt thereof and Tamarindus indica extract.

Abstract: The present invention relates to a pharmaceutical composition for use in the treatment of prostate pathologies. The present invention further relates to a composition comprising a mixture which comprises or, alternatively, consists of an effective amount Serenoa repens, Bromelain, Curcumin, Zinc, Lycopene and Selenium, and pharmaceutically acceptable or food grade technological excipients and/or additives. The present invention further relates to a pharmaceutical composition, preferably in the form of softgel capsules, for use in the treatment of disorders or diseases or pathologies connected to and/or deriving from prostatitis and/or benign prostatic hyperplasia.

Abstract: The present invention relates to a composition for oral use comprising an extract of Tamarindus indica, hyaluronic acid and/or its salts and at least one block copolymer of ethylene oxide and propylene oxide for the treatment of gastric and oesophageal diseases, in particular gastroesophageal reflux.

Abstract: The present invention relates to a composition for treatment and/or prevention of neurodegenerative diseases comprising at least a vegetable extract, an amide of a fatty acid and, optionally, a natural amino acid.

Abstract: Described herein is a synergistic composition of substances of natural origin, particularly effective in the treatment and prevention of osteoarticular diseases, such as rheumatoid arthritis and osteoarthritis. The composition includes the synergistic combination of aescin, at least one extract of a plant belonging to the genus Boswellia, and an extract of Scutellaria baicalensis. The synergistic composition may be provided in the form of pharmaceutical composition, food supplement, medical device, food for special medical purposes, or a cosmetic.

Abstract: A pharmaceutical composition containing a synergistic association of an extract of Pelargonium sidoides and lactoferrin for the prevention and treatment of respiratory tract diseases and for the stimulation of immune system is described.

Abstract: A composition containing a synergistic association of the extract of at least one plant belonging to the genus Plantago, glucomannan and at least an extract of camomile for the acute and chronic treatment of constipation.

Abstract: The present invention relates to a composition comprising ?-lipoic acid, Salvia miltiorrhiza extract and Curcumin, optionally further comprising ?-linolenic acid or borage oil. Furthermore, the present invention relates to the use of such composition for treating neuropathies.